SAN FRANCISCO, Jan. 27, 2023 (GLOBE NEWSWIRE) -- Insurance marketplace website Insuranks has recently updated its #" Featured Image for Insuranks Featured Image for Insuranks
Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology 1-08-2023, 19:23